The Man Who Blew the Whistle on One of the Deadliest Prescription Drugs Ever
"Blood Feud is the electrifying true tale of Big Pharma's power, regulatory weakness, and the terrifying vulnerability of millions of innocent patients. Procrit, an anti-anemia drug, this miraculous blood booster was one of the first biotech blockbusters. Developed by Amgen and licensed to a Johnson & Johnson company, the drug was sold by the two companies under the brand names Procrit, Epogen, and Arenesp. Mark Duxbury was the gung-ho salesman for the new biotech division of J&J, an irrepressible character full of jokes. In the early 1990s, he set out to spread the benefits of Procrit, and became a true believer and top seller. But he and his peers were told to steal business from J&J's partner, Amgen. Then came the marketing studies, the off-invoice rebates, doctor payments, and off-label claims. Duxbury tried to stop some of these ruthless programs, but was fired on trumped-up charges. He tried anything to warn the public: testifying in a secret arbitration, joining a class action effort, and filing a whistleblower suit. But he was thwarted at nearly every turn-until the surprising end."--From jacket.
New York : Dutton, c2011
Branch Call Number:
338.476153 S5318b 2011
viii, 424 p. ;,24 cm
From Library Staff
Medical drugs do all sorts of great things- they stop pain and cure illness, most of the time. While trying to get as much as they can from a drug they created a pharmacy company lies, cheats and steals. Where is the line between a drug that cures and a product that sells?